163 filings
Page 5 of 9
6-K
lu3mx5ue4dxbgq4nt53
28 Mar 19
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
5:17pm
6-K
33sb9
18 Mar 19
ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
8:43am
6-K
8vlevy5rtm6v
14 Mar 19
ESSA Pharma to Attend the 31st Annual ROTH Conference
8:24am
6-K
1662atx5v1xy3bms1
19 Feb 19
Statement of Executive Compensation
4:07pm
6-K
u6vwk i29l5ypmp
11 Feb 19
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
11:04am
6-K
iinf9sw5q2m8ch
7 Feb 19
Condensed Consolidated Interim Financial Statements
5:27pm
6-K
ut6sc95 1pjeyk3w
13 Dec 18
Current report (foreign)
5:21pm
6-K
r1bvxj 7zi0zbk8rms7
6 Nov 18
Current report (foreign)
1:13pm
6-K
hy2w0
22 Oct 18
ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors
9:49am
6-K
3rxch6r8boz q8va94j8
29 Aug 18
Current report (foreign)
12:00am
6-K
ewb85t5g
14 Aug 18
Condensed Consolidated Interim Financial Statements
7:18am
6-K
wuppf p0vufm3n
25 May 18
Current report (foreign)
12:00am
6-K
xltm3jvkhs7bn5
15 May 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
emuevd nalir5
11 May 18
Current report (foreign)
12:00am
6-K
1leflq7lcaqn5f jb
8 May 18
Current report (foreign)
12:00am
6-K
mya8nm
26 Apr 18
ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018
9:10am
6-K
jii3jlx 0jge
25 Apr 18
ESSA Pharma Inc. Announces Completion of Share Consolidation
12:00am
6-K
14pdbs2zqtmzoz5rc2tj
24 Apr 18
ESSA Pharma Enhances R&D Capabilities with Two New Key Hires
12:00am
6-K
b6fy7rygqw6n vzm
20 Apr 18
ESSA Pharma Inc. Announces Share Consolidation
12:00am
6-K
uoekm3fb9uc8sx23ewl
29 Mar 18
ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders
12:00am